JRCT ID: jRCT2080220729
Registered date:08/05/2009
Basic Information
Recruitment status | |
---|---|
Health condition(s) or Problem(s) studied | Gynecologic Disease |
Date of first enrollment | 08/05/2009 |
Target sample size | |
Countries of recruitment | |
Study type | Interventional |
Intervention(s) | investigational material(s) Generic name etc : ZO-Y49 INN of investigational material : Therapeutic category code : 29- Other agents affecting individual organs Dosage and Administration for Investigational material : Oral |
Outcome(s)
Primary Outcome | Safety, Efficacy |
---|---|
Secondary Outcome |
Key inclusion & exclusion criteria
Age minimum | >= 18age old |
---|---|
Age maximum | Not applicable |
Gender | Female |
Include criteria | Out patients who can understand the content of this trial and from whom a written informed consent to participate in this study can be directly obtained. In addition, in the case of patients whose age is less than 20 years old when the informed consent is obtained, the patients from whose representative a written informed consent must be obtained too. |
Exclude criteria |
Related Information
Primary Sponsor | ZERIA Pharmaceutical Co.,Ltd. |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | |
Secondary ID(s) | JapicCTI-090757 |
Contact
Public contact | |
Name | |
Address | 03-5644-7053 |
Telephone | |
Affiliation | ZERIA Pharmaceutical Co.,Ltd. |
Scientific contact | |
Name | |
Address | |
Telephone | |
Affiliation |